Answer
Patients taking entrectinib (Rozlytrek) should not drive or use machines until symptoms resolve if they experience cognitive adverse reactions, syncope (fainting), blurred vision or dizziness.
Sources for this answer
- Rozlytrek 100 mg & 200 mg hard capsulesRoche Products Limited · emc · SmPC §4.7 Effects on ability to drive and use machines · Version 16Document updated
Sources checked